MedDataX Logo

Phenotypic and Genotypic Characterization of Escherichia Coli

NCT ID: NCT06462261

Last Updated: 2024-06-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-07-01

Study Completion Date

2025-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Collection of urine samples Cultivation Antibiotic sensitivity test PCR

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Phenotypic and Genotypic Variations of Enterococcus Spp

NCT05751317

Isolation of Enterococci From Samples Demonstration of Enterococci Antibiotic Susceptibility Detection of Strains Enterococci Produce Biofilm +3 more
UNKNOWN

Detection of Biofilm Among Uropathogenic Escherichia Coli Clinical Isolates in Suez Canal University Hospitals

NCT06252428

Escherichia Coli Infections
COMPLETED

Characterization of Enterococci

NCT04777240

Samples From Patients With Enterococcal Infections
COMPLETED

Antimicrobial Resistance Rate In Escherichia Coli And Klebsiella Pneumonia : A Retrospective Study

NCT04196387

Antibiotic Reaction
COMPLETED

Detection of Anaerobes in Different Clinicalsamples

NCT03266341

Anaerobic Bacterial Infection
UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Cultivation on MaCconkey and EMB IMVC test Dis diffusion test Detection of virulence and antibiotic resistance genes by PCR

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Antibiotic Sensitivity Testing and Genotypic Caharacterization of Ecoli

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group 1

Escherichia coli isolates

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

\- Catheter associated urinary tract infections in patient with catheter more than two 2 days .fever.urine culture with no more than 2 species organisation catheterization .fever.suprapubic tenderness with urine culture more than 105 CFU/Ml

Exclusion Criteria

* asymptomatic bacteriuria UTI before 48 hrs
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Sohag University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Yassmin Hassan Mahmoud

Principal investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Soh-Med-24-03-01MS

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Can the Relative Fecal Abundance of BLSE and the Digestive Microbiota be Predictive of the Risk of Infection in a Carrier Patient?
NCT04699981 UNKNOWN NA
Selective Reporting for Antibiotic Susceptibility Testing and GPs' Prescribing of Broad-spectrum Antibiotics in Women With E. Coli UTIs
NCT06067386 UNKNOWN NA
Dynamics of the Urinary Bacterial Microbiota
NCT07020676 COMPLETED
Resistance Profile of Escherichia Coli in Infections of Community Origin: The Importance of Antimicrobial Stewardship
NCT06305455 NOT_YET_RECRUITING
Antibiotic Resistant Community-Acquired E. Coli
NCT00298103 COMPLETED
Establish Quantitative PCR to Measure Bacteria Load of the VRE Bacteremia
NCT01265095 UNKNOWN
Community Antibiotic Use, Susceptibility and ResisTance Among Patients With Urinary Tract Infections (CAST-UTI)
NCT07012421 RECRUITING
Antimicrobial Combination Therapy for Treatment of Enterococcus Faecalis Bacteremia
NCT06833593 RECRUITING
Surveillance Study of Candiduria in Hospitalized Patients
NCT03910764 COMPLETED
Urinary Tract Infections Caused by ESBL-producing Enterobacteria
NCT03501901 COMPLETED
Analysis of Risk Factors for Surgical Site Infections in Patients With Acute Abdomen at Hospital of State University of Haiti
NCT06480344 COMPLETED
Transmission of ESBL-producing Enterobacteriaceae
NCT03465683 RECRUITING
From Commensalism to Pathogenicity: Exploring the Pathophysiology of Bacteremia to Better Understand Enterococcus Faecalis Infective Endocarditis
NCT07313865 NOT_YET_RECRUITING NA
Concomitant Infection of Intestinal Parasites and Helicobacter Pylori
NCT05360940 UNKNOWN
Burden of Antibiotic Resistance in Gram-Negative Infections in Dutch Hospitals
NCT02007343 COMPLETED
Community - Associated Extended-spectrum Beta-lactamases (ESBL)
NCT00363220 COMPLETED
Clinical Significance and Optimal Treatment of Community-onset Urinary Tract Infections Caused by Extended-spectrum β-lactamase and/or AmpC β-lactamase Producing Enterobacteriaceae
NCT01138566 UNKNOWN
Prognostic Factors of Escherichia Coli Bloodstream Infections: Severity Score and Therapeutic Implications
NCT02890901 COMPLETED
Clinical and Microbiologic Characteristics of Cephalosporin-Resistant E. Coli-PITT Protocol
NCT00877708 COMPLETED
Clinical Evaluation of Beta-Lacta ™ Test in Urinary Infections
NCT02897609 COMPLETED
The Clinical Impact of Cobas® Eplex Blood Culture Panels for the Diagnosis of Bacteremia and Fungemia
NCT06576258 RECRUITING NA
PK/PD Analysis of Ceftazidime/Avibactam or Cefiderocol With or Without Fosfomycin for the Treatment of Difficult To-treat Gram-negative Infections
NCT06651047 RECRUITING
Reporting Patterns and Results of Initial Antibiotic Treatment in Patients With cUTI, cIAI,NP Including VAP
NCT02364284 COMPLETED
The Association Between Advancing Age and Mortality at 30 Days in Patients With Bacteremia E. Coli Beta-lactamase Phenotype Extended Spectrum RC15_0421
NCT02847065 COMPLETED
Biofilms on Short-term Indwelling Ureteral Stents
NCT02845726 COMPLETED